Salmeri N, Ragusi A, Buffo C, Somigliana E, Vigan P, Vercellini P
This is important because TNF-alpha is a driver of inflammation in IBD and a target of current therapeutics like infliximab (Remicade/Inflectra) and adalimumab (Humira)
As a professional company, BOC Sciences has directed sincere efforts toward providing customers a broad range of quality pharmaceutical intermediates at very competitive costs
In preclinical and in vitro studies, GHK-Cu is being researched in relation to collagen formation in skin cells, antioxidant and inflammation-related processes, tissue repair and the regulation of gene expression
Accelerated Wound Healing Enhances collagen synthesis, fibroblast activity, and angiogenesis